|
|
INVESTIGATING THE LONGITUDINAL PATTERNS OF USE AND COMPARATIVE EFFECTIVENESS OF BETA BLOCKER THERAPY IN THE HEMODIALYSIS POPULATION |
| 1F32DK109561-01 |
ASSIMON, MAGDALENE MARIE |
NIDDK |
2016 |
|
|
OUTCOMES OF VASCULAR DIALYSIS ACCESS IN THE ELDERLY |
| 1K08DK107934-01A1 |
WOO, KAREN |
NIDDK |
2016 |
|
|
HIGH-THROUGHPUT SCREENING FOR DAB2 INHIBITORS AS STABILIZERS OF CFTR |
| 1R01DK104847-01A1 |
MADDEN, DEAN R. |
NIDDK |
2016 |
|
|
THE CONSEQUENCES OF REPEAT EXPANSION IN THE FRAGILE X-RELATED DISORDERS |
| 1ZIADK057602-20 |
USDIN, KAREN P. |
NIDDK |
2016 |
|
|
MECHANISM OF REPEAT EXPANSION AND CHROMOSOME FRAGILITY IN FRAGILE X SYNDROME |
| 1ZIADK057808-10 |
USDIN, KAREN P. |
NIDDK |
2016 |
|
|
MUSCARINIC ACETYLCHOLINE RECEPTOR SUBTYPES: PHYSIOLOGICAL ROLES |
| 1ZIADK075020-08 |
WESS, JURGEN |
NIDDK |
2016 |
|
|
APS STEP-UP: PROMOTING DIVERSITY THROUGH RESEARCH EXPERIENCES AND PROFESSIONAL SO |
| 4R25DK095492-05 |
MATYAS, MARSHA LAKES |
NIDDK |
2016 |
|
|
INNOVATION AND LEADERSHIP IN ENGINEERING TECHNOLOGIES AND THERAPIES FOR DIABETES |
| 4R90DK098981-05 |
BABENSEE, JULIA E |
NIDDK |
2016 |
|
|
INNOVATION & LEADERSHIP IN ENGINEERING TECHNOLOGIES AND THERAPIES FOR DIABETES |
| 4T90DK097787-05 |
BABENSEE, JULIA E |
NIDDK |
2016 |
|
|
HEMATOPOIESIS IN DOWN SYNDROME IPS CELLS: CORRECTION BY CHROMOSOME 21 SILENCING |
| 5R01DK100960-03 |
LAWRENCE, JEANNE BENTLEY |
NIDDK |
2016 |
